Gillian A Hawker

Women's College Research Institute, Toronto, Ontario, Canada

Are you Gillian A Hawker?

Claim your profile

Publications (240)1145.07 Total impact

  • G.A. Hawker, I. Stanaitis
    [Show abstract] [Hide abstract]
    ABSTRACT: A systematic search was conducted for the time period April 1 2013 to March 30 2014 using PubMed to identify major osteoarthritis (OA) clinical research themes of the past year. Articles within each theme were selected for inclusion in this review based on study quality and relevance. Two major themes emerged, which relate to the current understanding of OA as a heterogeneous condition with multiple pathogenic mechanisms and clinical manifestations. Theme 1 stems from the role of systemic inflammation in OA pathogenesis, and the concept of 'metabolic OA'. Over the past year, research has examined the effect of OA on incidence and progression of other 'metabolic syndrome'-related conditions, especially cardiovascular disease (CVD) and diabetes and the impact of multi-morbidity on the clinical management of OA. Theme 2 focuses on the concept of personalized medicine as it relates to the treatment of OA. It is hypothesized that the modest efficacy of available OA treatments is a result of inclusion of heterogeneous groups of OA patients in clinical trials. Prognostic studies in the past year have been helpful in identifying 'OA phenotypes' that are more or less likely to respond to treatments - e.g., the presence of synovitis on imaging, central pain sensitization on quantitative sensory testing (QST), or coping efficacy by self-reported patient questionnaire. Their findings are being increasingly used to target interventions to these identified 'OA responder' subgroups with the hopes that treatment effect will be amplified. Copyright © 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
    Osteoarthritis and Cartilage 11/2014; · 4.26 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: While some studies have identified patient readiness as a key component in their decision whether to have total joint replacement surgery (TJR), none have examined how patients determine their readiness for surgery. The study purpose was to explore the concept of patient readiness and describe the factors patients consider when assessing their readiness for TJR.
    BMC Health Services Research 10/2014; 14(1):454. · 1.77 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Hospital readmissions are common and costly, and no single intervention or bundle of interventions has reliably reduced readmissions. Virtual wards, which use elements of hospital care in the community, have the potential to reduce readmissions, but have not yet been rigorously evaluated.
    JAMA. 10/2014; 312(13):1305-1312.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Aim of Investigation: The association of comorbid low back pain (LBP) with hip and knee osteoarthritis (OA) is reported in the literature as having an additive effect on OA pain related disability. It is also established in both LBP and OA populations that psychosocial variables are associated with poor outcomes. It is unknown if the additive effect of LBP to hip/knee OA on future pain related disability differs depending on baseline psychosocial factors. It was therefore our intent to examine if the effect of psychosocial variables on pain impact (PI) in people with hip and knee OA differs in those with and without LBP. We hypothesized that PI would be associated with pain catastrophizing, depression, anxiety, fatigue, and social support and that the magnitude of the effect would be amplified in those with LPB. Methods: We analyzed data from an established population-based cohort of residents from Ontario, Canada who were 55 years or older and reported symptomatic hip/knee OA. Initial recruitment occurred between 1995 and 1997 through screening of 100% of the population in two communities. An initial cohort of n=2411 was followed annually using telephone interviews. The current study utilized data collected in 2006 (baseline) and 2008 (follow-up). Participants with inflammatory arthritis or a prior total joint replacement were excluded resulting in an analyzable sample of 462. The primary outcome was PI at follow-up using the Pain Impact Questionnaire 6 item version. The following standardized baseline measures were used for our independent variables: Pain Catastrophizing Scale, the Centre for Epidemiologic Studies Depression Scale, The Hospital Anxiety and Depression Scale –anxiety subscale, Profile of Moods States – fatigue inertia subscale; the abbreviated Lubben Social Network Scale and the Western Ontario and McMaster Universities’ Osteoarthritis Index (WOMAC). Persistent LBP in the past year (yes/no) was identified from a comorbidities questionnaire. Bivariate analyses compared participants with and without LBP. Next a sequential series of four linear regression analyses with the listed independent variables were conducted in the following order: 1. Psychosocial variables; 2. Psychosocial variables and LBP; 3. Psychosocial variables, LBP and demographics (age, sex, marital status, education); and 4. Psychosocial variables, LBP, demographics and disease-related variables (WOMAC, knee pain (yes/no), hip pain, hip and knee pain, BMI, number of comorbidities). Given the results, we then proceeded to test if WOMAC mediated the effect of fatigue, pain catastrophizing (PC) and LBP on pain impact. Analyses were conducted with multiple imputation for missing values on the independent variables. Results: In 462 participants, the mean age was 76 years (range 58 to 96), most were female (77%) and 35% reported LBP at baseline. Bivariate analyses revealed significant differences between those with and without LBP (p<0.05) in all psychosocial variables, with those with LBP having greater PC, depression, anxiety, fatigue and smaller social networks. Initial regression analyses demonstrated that PC, fatigue, LBP and female gender predicted pain impact at follow-up. When WOMAC summary score was added to the model, only it and female gender were significant. Subsequent testing of the mediation model showed that WOMAC fully mediated the effect of PC and LBP on pain impact [ß 0.367 (0.173, 0.561) p=0.002]. The effect of full mediation by the WOMAC was present in people with and without LBP. Conclusions: In our population-based cohort, WOMAC fully mediated the effects of PC and LBP on PI indicating that interventions directly addressing disease severity are the most effective way to mitigate PI related to hip and knee OA. However, given that baseline psychological variables and future PI were worse in those with LBP, these interventions may need to be tailored. Identification of the role of LBP and its contribution to pain mechanisms may attenuate future PI. Interventions addressing PC that improve perceptions of disease severity may limit the future negative impact of pain.
    World Congress on Pain; 10/2014
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective Therapeutic intra-articular injections are used in the management of hip osteoarthritis (OA). Some studies suggest their use increases risk for infection, and thus revision, after THA, while others do not. We sought to clarify the relationship between prior intra-articular injection and the risk of complication in a subsequent total hip arthroplasty (THA).Methods In a cohort with hip OA who received a primary elective THA between 2002 and 2009, we identified those who received ≥1 intra-articular injection by a radiologist in the five years preceding their THA. Multivariable Cox proportional hazards models were used to determine the relationship between receipt of a pre-surgical injection (none, 1-5 years prior, or < 1year prior) and the occurrence of post-surgical joint infection and revision THA in the following 2 years, while controlling for confounders.ResultsOf 37,881 eligible THA recipients, 2,468 (6.5%) received an intra-articular injection from a radiologist within five years of their THA (<1y: 1,691; 1-5years: 777). Controlling for age, sex, co-morbidity, frailty, income, and provider volume, those who had an injection in the year preceding surgery were at increased risk for infection (adjusted HR 1.37, p=0.03) and revision (adjusted HR 1.53, p=0.03) within 2 years of the THA, relative to patients that did not. The association between prior injection and revision arthroplasty was attenuated and became non-significant (adjusted HR 1.41, p=0.13) after occurrence of post-operative infection was included in the regression model. No effect was found for injection 1-5 years prior to surgery.Conclusions Intra-articular injection in the year preceding THA independently predicted increased risk for infection leading to early revision. Further studies are warranted to elucidate explanations for these findings. © 2014 American College of Rheumatology.
    Arthritis & Rheumatology. 09/2014;
  • Source
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: A link between obstructive sleep apnea and cancer development or progression has been suggested, possibly through chronic hypoxemia, but supporting evidence is limited. We examined the association between the severity of obstructive sleep apnea and prevalent and incident cancer, controlling for known risk factors for cancer development.
    08/2014;
  • [Show abstract] [Hide abstract]
    ABSTRACT: We examined patients' experiences regarding bone mineral density (BMD) testing and bone health treatment after being screened through Ontario's Fracture Clinic Screening Program. Provider-level barriers to testing and treatment appeared to be as significant as patient-level barriers and potentially had more of an impact on treatment than on testing.
    08/2014;
  • [Show abstract] [Hide abstract]
    ABSTRACT: To estimate the current and future (to year 2032) impact of osteoarthritis health care seeking.
    Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society. 07/2014;
  • [Show abstract] [Hide abstract]
    ABSTRACT: To examine messages perceived by members of an osteoporosis (OP) patient group from various healthcare providers regarding bone health. We conducted a phenomenological (qualitative) study in members of an OP patient group who resided in Canada, had sustained a fragility fracture at 50+ years old, and were not taking antiresorptive medication at the time of that fracture. Participants were interviewed for approximately 1 h by telephone and responded to questions about visits to healthcare providers for their bone health and what was discussed during those visits. We analyzed the data guided by Giorgi's methodology. We interviewed 28 members (2 males, 26 females; 78 % response rate), aged 51-89 years old. Most participants perceived that their specialist was more interested than their primary care physician in bone health and took the time to discuss issues with them. Participants perceived very few messages from the fracture clinic and other providers. We found many instances where perceived messages within and across various healthcare providers were inconsistent, suggesting there is a need to raise awareness of bone health management guidelines to providers who treat fracture patients.
    Rheumatology International 06/2014; · 2.21 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Rationale: Despite emerging evidence that obstructive sleep apnea (OSA) may cause metabolic disturbances independently of other known risk factors, it remains unclear whether OSA is associated with incident diabetes. Objective: To evaluate whether risk of incident diabetes was related to the severity and physiological consequences of OSA. Methods and Measurements: A historical cohort study was conducted using a clinical and provincial health administrative data. All adults without previous diabetes referred with suspected OSA who underwent a diagnostic sleep study at St Michael's Hospital (Toronto, Canada) between 1994 and 2010 were followed through health administrative data until May 2011 to examine the occurrence of diabetes. All OSA-related variables collected from the sleep study were examined as predictors in Cox-regression models, controlling for sex, age, body mass index, smoking status, comorbidities and income. Main Results: Over a median follow-up of 67 months, 1,017 (11.7%) of 8,678 patients developed diabetes, giving a cumulative incidence at five years of 9.1% (95%CI: 8.4% to 9.8%). In fully-adjusted models, patients with apnea-hypopnea index (AHI) > 30 had a 30% higher hazard of developing diabetes than those with AHI < 5. Among other OSA-related variables, AHI in rapid eye movement (REM) sleep, and time spent with oxygen saturation less than 90% were associated with incident diabetes, as were heart rate, neck circumference and sleep time. Conclusions: Among people with OSA, and controlling for multiple confounders, initial OSA severity and its physiologic consequences predicted subsequent risk for incident diabetes.
    American Journal of Respiratory and Critical Care Medicine 06/2014; · 11.04 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To identify a cut point in annual surgeon volume associated with increased risk of complications after primary elective total hip arthroplasty and to quantify any risk identified.DESIGN: Propensity score matched cohort study.SETTING: Ontario, CanadaPARTICIPANTS: 37 881 people who received their first primary total hip arthroplasty during 2002-09 and were followed for at least two years after their surgery.MAIN OUTCOME MEASURE: The rates of various surgical complications within 90 days (venous thromboembolism, death) and within two years (infection, dislocation, periprosthetic fracture, revision) of surgery.RESULTS: Multivariate splines were developed to visualize the relation between surgeon volume and the risk for various complications. A threshold of 35 cases a year was identified, under which there was an increased risk of dislocation and revision. 6716 patients whose total hip arthroplasty was carried out by surgeons who had done ≤35 such procedure in the previous year were successfully matched to patients whose surgeon had carried out more than 35 procedures. Patients in the former group had higher rates of dislocation (1.9% v 1.3%, P=0.006; NNH 172) and revision (1.5% v 1.0%, P=0.03; NNH 204).CONCLUSIONS: In a cohort of first time recipients of total hip arthroplasty, patients whose operation was carried by surgeons who had performed 35 or fewer such procedures in the year before the index procedure were at increased risk for dislocation and early revision. Surgeons should consider performing 35 cases or more a year to minimize the risk for complications. Furthermore, the methods used to visualize the relationship between surgeon volume and the occurrence of complications can be easily applied in any jurisdiction, to help inform and optimize local healthcare delivery.
    BMJ Clinical Research 05/2014; 348:g3284. · 14.09 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Introduction & Objective: Obstructive sleep apnea (OSA) has been postulated to cause cancer, possibly through chronic hypoxemia, but the evidence on this relationship is limited. Our objective was to explore the association between OSA severity, expressed by apnea-hypopnea index (AHI) and oxygen desaturation, and either prevalent or incident cancer after controlling for known risk factors for cancer such as older age, smoking, and being overweight. Methods: All adults who were referred with suspected OSA and underwent a first diagnostic sleep study at St Michael’s Hospital (Toronto, Canada) between 1994 and 2010, were included. Patient data was linked to Ontario health administrative data from 1991 to 2013. Two outcomes were explored: prevalent and incident cancer derived from the Ontario Cancer Registry. Logistic regression analysis was performed to predict prevalent cancer at baseline among patients with OSA. In a cohort free of cancer at baseline, Cox regression models were used to investigate the relationships between OSA and incident cancer. Models controlled for known risk factors. Results: In total, 10,149 subjects were included in our analyses. Participants with prevalent cancer at baseline (n=520) were older, with a higher percentage of ex-smokers, a greater number of comorbid conditions, more severe OSA, and higher mortality compared to those without cancer. Over a median follow-up of 93 months, 627 of 9,629 participants (6.5%) developed incident cancer. Cumulative incidence of cancer at 5 years for the entire cohort was 3.7% (95%CI: 3.3-4.0) and decreased significantly with greater baseline OSA severity (2.6% for AHI<5 vs. 4.9% for AHI>30). In multivariable regression models OSA severity was not a significantly associated with either prevalent or incident cancer controlling for age, sex, body mass index and smoking status at baseline. Conclusions: In a large cohort, OSA was not found to be independently associated with either prevalent or incident cancer. Additional studies are needed to elucidate whether there is an independent effect of OSA on specific types of cancer.
    2014 American Thoracic Society (ATS) International Conference in San Diego, California, May 17 - May 20; 05/2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Internationally, chronic disease self-management programs (CDSMPs) have been widely promoted with the assumption that confident, knowledgeable patients practicing self-management behavior will experience improved health and utilize fewer healthcare resources. However, there is a paucity of published data supporting this claim and the majority of the evidence is based on self-report.
    BMC Health Services Research 05/2014; 14(1):198. · 1.77 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Because individuals with osteoarthritis (OA) avoid physical activities that exacerbate symptoms, potentially increasing risk for cardiovascular disease (CVD) and death, we assessed the relationship between OA disability and these outcomes. In a population cohort aged 55+ years with at least moderately severe symptomatic hip and/or knee OA, OA disability (Western Ontario McMaster Universities (WOMAC) OA scores; Health Assessment Questionnaire (HAQ) walking score; use of walking aids) and other covariates were assessed by questionnaire. Survey data were linked to health administrative data to determine the relationship between baseline OA symptom severity to all-cause mortality and occurrence of a composite CVD outcome (acute myocardial infarction, coronary revascularization, heart failure, stroke or transient ischemic attack) over a median follow-up of 13.2 and 9.2 years, respectively. Of 2156 participants, 1,236 (57.3%) died and 822 (38.1%) experienced a CVD outcome during follow-up. Higher (worse) baseline WOMAC function scores and walking disability were independently associated with a higher all-cause mortality (adjusted hazard ratio, aHR, per 10-point increase in WOMAC function score 1.04, 95% confidence interval, CI 1.01-1.07, p = 0.004; aHR per unit increase in HAQ walking score 1.30, 95% CI 1.22-1.39, p<0.001; and aHR for those using versus not using a walking aid 1.51, 95% CI 1.34-1.70, p<0.001). In survival analysis, censoring on death, risk of our composite CVD outcome was also significantly and independently associated with greater baseline walking disability ((aHR for use of a walking aid = 1.27, 95% CI 1.10-1.47, p = 0.001; aHR per unit increase in HAQ walking score = 1.17, 95% CI 1.08-1.27, p<0.001). Among individuals with hip and/or knee OA, severity of OA disability was associated with a significant increase in all-cause mortality and serious CVD events after controlling for multiple confounders. Research is needed to elucidate modifiable mechanisms.
    PLoS ONE 04/2014; 9(3):e91286. · 3.53 Impact Factor
  • Osteoarthritis and Cartilage 04/2014; 22:S16. · 4.26 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Fracture risk assessments on bone mineral density reports guide family physicians' treatment decisions but are subject to inaccuracy. Qualitative analysis of interviews with 22 family physicians illustrates their pervasive questioning of reported assessment accuracy and independent assumption of responsibility for assessment. Assumption of responsibility is common despite duplicating specialists' work. Fracture risk is the basis for recommendations of treatment for osteoporosis, but assessments on bone mineral density (BMD) reports are subject to known inaccuracies. This creates a complex situation for referring physicians, who must rely on assessments to inform treatment decisions. This study was designed to broadly understand physicians' current experiences with and preferences for BMD reporting; the present analysis focuses on their interpretation and use of the fracture risk assessments on reports, specifically METHODS: A qualitative, thematic analysis of one-on-one interviews with 22 family physicians in Ontario, Canada was performed. The first major theme identified in interview data reflects questioning by family physicians of reported fracture risk assessments' accuracy. Several major subthemes related to this included questioning of: 1) accuracy in raw bone mineral density measures (e.g., g/cm(2)); 2) accurate inclusion of modifying risk factors; and 3) the fracture risk assessment methodology employed. A second major theme identified was family physicians' independent assumption of responsibility for risk assessment and its interpretation. Many participants reported that they computed risk assessments in their practice to ensure accuracy, even when provided with assessments on reports. Results indicate family physicians question accuracy of risk assessments on BMD reports and often assume responsibility both for revising and relating assessments to treatment recommendations. This assumption of responsibility is common despite the fact that it may duplicate the efforts of reading physicians. Better capture of risk information on BMD referrals, quality control standards for images and standardization of risk reporting may help attenuate some inefficiency.
    Osteoporosis International 03/2014; · 4.04 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: On Apr. 1, 2008, a revision was made to the fee schedule for bone mineral density testing with dual-energy x-ray absorptiometry (DXA) in the province of Ontario, Canada, reducing the frequency of repeat screening in individuals at low risk of osteoporosis. We evaluated whether the change in physician reimbursement successfully promoted appropriate bone mineral density testing, with reduced use among women at low risk and increased use among women and men at higher risk of osteoporosis-related fracture. Methods: We analyzed data from administrative databases on physician billings, hospital discharges and emergency department visits. We included all physician claims for DXA in the province to assess patterns in bone mineral density testing from Apr. 1, 2002, to Mar. 31, 2011. People at risk of an osteoporosis-related fracture were defined as women and men aged 65 years or more and those who had a recent (< 6 mo) fracture after age 40 years. Joinpoint regression analysis was used to examine trends in DXA testing. Results: Before the policy change, the overall number of DXA tests increased from 433 419 in 2002/03 to 507 658 in 2007/08; after revision of the fee schedule, the number decreased to 422 915 by 2010/11. Most of this reduction was due to a decrease in the age-standardized rate of DXA testing among women deemed to be at low risk, from 5.7 per 100 population in 2008/09 to 1.8 per 100 in 2010/11. In the high-risk group of people aged 65 or more, the age-standardized rate of testing increased after the policy change among men but decreased among women. Among those at high risk because of a recent clinical fracture, the age-standardized rate of DXA testing increased for both sexes and then decreased after the policy change. Interpretation: A change in reimbursement designed to restrict access to bone mineral density testing among low-risk women was associated with an overall reduction in testing. Efforts to communicate guidelines for bone mineral density testing with greater clarity, particularly as they relate to high-risk individuals, need to be explored.
    CMAJ Open. 03/2014; 2(2):E45-E50.
  • [Show abstract] [Hide abstract]
    ABSTRACT: To determine the relationship between surgeon experience with, and complications following, total joint arthroplasty (TJA) in patients with rheumatoid arthritis (RA). Using administrative data, we assembled a cohort of patients with RA who had undergone at least 1 elective primary hip or knee replacement procedure between 2002 and 2009. Cox proportional hazards, censored on death and accounting for clustering of patients within surgeons, were used to determine the relationship between overall and "RA-specific" surgeon TJA volume and the occurrence of a composite "complication" outcome (revision, infection, dislocation, or periprosthetic fracture within 2 years of the initial TJA), controlling for potential confounders (patient age, sex, comorbidity, and disease severity). We identified 4,762 patients with RA who were eligible for TJAs (1,515 total hip arthroplasties and 3,247 total knee arthroplasties). Among these patients, 152 (3.2%) experienced a surgical complication within 2 years of the procedure. After controlling for patient and hospital factors, greater surgeon TJA volume in patients with RA (RA TJA), but not overall TJA volume (all TJA), was associated with a reduced risk of complications (for surgeon RA TJA volume per 10 cases, adjusted hazard ratio [HR] 0.81, 95% confidence interval [95% CI] 0.71-0.93, P = 0.002; for surgeon all TJA volume, adjusted HR 0.98, 95% CI 0.97-1.00, P = 0.09). In a cohort of patients with RA who underwent hip or knee TJA, increased surgeon experience performing TJA in patients with RA, irrespective of their overall TJA experience and hospital factors, was associated with a decreased risk of surgical complications. These findings have potential implications for surgeon training and the referral practices of rheumatologists.
    Arthritis & rheumatology (Hoboken, N.J.). 03/2014; 66(3):488-96.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To evaluate feasibility and potential effectiveness of a patient decision aid (PtDA) for patients and a preference report for surgeons to reduce wait times and improve decision quality in patients with osteoarthritis considering total knee replacement. A prospective two-arm pilot randomized controlled trial. Patients with osteoarthritis were eligible if they understood English and were referred for surgical consultation about an initial total knee arthroplasty at a Canadian orthopaedic joint assessment clinic. Patients were randomized to the PtDA intervention or usual education. The intervention was an osteoarthritis PtDA for patients and a one-page preference report summarizing patients' clinical and decisional data for their surgeon. The main feasibility outcomes were rates of recruitment and questionnaire completion; the preliminary effectiveness outcomes were wait times and decision quality. Of 180 patients eligible for surgical consultation, 142 (79%) were recruited and randomized to the PtDA intervention (n = 71) or usual education (n = 71). Data collection yielded a 93% questionnaire completion rate with less than 1% missing items. After one year, 13% of patients remained on the surgical wait list. The median time from referral to being off the wait list (censored using survival analysis techniques) was 33.4 weeks for the PtDA group (n = 69, 95% CI: 26.0, 41.4) and 33.0 weeks for usual education (n = 71, 95% CI: 26.1, 39.9). Patients exposed to the PtDA had higher decision quality based on knowledge (71% versus 47%; p < 0.0001) and quality decision being an informed choice that is consistent with their values for option outcomes (56.4% versus 25.0%; p < 0.001). Recruitment of patients with osteoarthritis considering surgery and data collection were feasible. As some patients remained on the surgical waiting list after one year, follow-up should be extended to two years. Patients exposed to the PtDA achieved higher decision quality compared to those receiving usual education but there was no difference in wait for surgery.Trials registration: ClinicalTrials.Gov NCT00743951.
    BMC Musculoskeletal Disorders 02/2014; 15(1):54. · 1.88 Impact Factor

Publication Stats

7k Citations
1,145.07 Total Impact Points

Institutions

  • 2014
    • Women's College Research Institute
      Toronto, Ontario, Canada
  • 2003–2014
    • Institute for Clinical Evaluative Sciences
      Toronto, Ontario, Canada
  • 1995–2014
    • Women's College Hospital
      Toronto, Ontario, Canada
  • 1993–2014
    • University of Toronto
      • • Department of Medicine
      • • Institute for Clinical Evaluative Sciences
      • • Faculty of Medicine
      • • Division of Rheumatology
      Toronto, Ontario, Canada
    • Newton-Wellesley Hospital
      Boston, Massachusetts, United States
  • 2012
    • Dalhousie University
      • College of Pharmacy
      Halifax, Nova Scotia, Canada
  • 2008–2012
    • Toronto Western Hospital
      Toronto, Ontario, Canada
  • 2011
    • St. Michael's Hospital
      Toronto, Ontario, Canada
  • 2007–2011
    • Université René Descartes - Paris 5
      • Faculté de Médecine
      Paris, Ile-de-France, France
  • 2010
    • University of Massachusetts Boston
      Boston, Massachusetts, United States
  • 2009–2010
    • University of Bristol
      Bristol, England, United Kingdom
    • McMaster University
      • Department of Clinical Epidemiology and Biostatistics
      Hamilton, Ontario, Canada
    • Centre Hospitalier Universitaire de Dijon
      Dijon, Bourgogne, France
    • University of British Columbia - Vancouver
      • School of Population and Public Health
      Vancouver, British Columbia, Canada
  • 2005–2010
    • University Health Network
      • • Division of Healthcare and Outcomes Research
      • • Department of Medicine
      Toronto, Ontario, Canada
  • 2006–2009
    • University of Ottawa
      • • Institute of Population Health
      • • Department of Medicine
      Ottawa, Ontario, Canada
    • University of Burgundy
      Dijon, Bourgogne, France
  • 2002–2008
    • SickKids
      Toronto, Ontario, Canada
  • 2003–2006
    • Sunnybrook Health Sciences Centre
      Toronto, Ontario, Canada
  • 2001
    • Harbor-UCLA Medical Center
      Torrance, California, United States
  • 1999
    • Mount Sinai Hospital, Toronto
      Toronto, Ontario, Canada
  • 1997
    • Institute for Work and Health
      Toronto, Ontario, Canada
  • 1996
    • Indiana University-Purdue University Indianapolis
      • Department of Biostatistics
      Indianapolis, IN, United States